Diabetes mellitus is a major global health challenge, and insulin remains an essential treatment for many people with diabetes. Conventional basal insulin therapy commonly requires daily injections. The development of once-weekly basal insulin is therefore an important advance in drug delivery, aiming to reduce treatment burden while maintaining effective basal insulin coverage.
Read Article →No blogs found matching your search.